论文部分内容阅读
作者采用自制的LAK细胞冻融提取液作体内外抗肿瘤的实验研究.结果表明:每天每小鼠用LAK细胞冻融提取液0.2ml治疗,可使小鼠肝癌实体瘤H22抑瘤率达51%(腹腔注射)和65%(肿瘤局部注射).体外实验显示,LAK细胞冻融提取液对K562和Raji细胞均有较强的抗瘤作用,其杀瘤活性分别为68.5±0.85%和58.2±2.01%.
The authors used a self-made LAK cell freeze-thaw extract as an anti-tumor study in vitro and in vivo. The results showed that daily treatment with a 0.2 ml LAK cell freeze-thaw extract resulted in an inhibition rate of 51 tumor-bearing H22 tumors in mice. % (intraperitoneal injection) and 65% (local injection of tumor). In vitro experiments showed that LAK cell freeze-thaw extracts had strong anti-tumor effect on K562 and Raji cells, and their tumoricidal activity was 68.5±0.85% and 58.2 respectively. ±2.01%.